Sagimet Biosciences SGMT
NASDAQ SGMT
$9.58 -0.37 (-3.72%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sagimet Biosciences (SGMT) Sale and Maturity of Investments (2022 - 2026)

Updated

Analysis

Sagimet Biosciences (SGMT) Sale and Maturity of Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Sagimet Biosciences 508.84 Mn -65.65 Mn - 15.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.88 Mn
Mar 31, 2026 16.97 Mn
Dec 31, 2025 31.43 Mn
Sep 30, 2025 31.34 Mn
Jun 30, 2025 29.66 Mn
Mar 31, 2025 18.99 Mn
Dec 31, 2024 23.61 Mn
Sep 30, 2024 12.00 Mn
Jun 30, 2024 7.80 Mn
Mar 31, 2024 3.00 Mn
Jun 30, 2023 12.80 Mn
Mar 31, 2023 19.40 Mn
Dec 31, 2022 5.44 Mn
API Access

Sagimet Biosciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=SGMT&period=max&api_key=YOUR_API_KEY